Clueso vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 25)
Clueso logo

Clueso

EmergingProfessional Services

General

SF YC W23 AI documentation platform converting screen recordings to studio-quality videos and articles in 16+ languages; $1.9M F7/Shift Left seed at 80% time reduction competing with Scribe and Guidde for SaaS product documentation automation.

AI VisibilityBeta
Overall Score
D25
Category Rank
#886 of 1158
AI Consensus
61%
Trend
up
Per Platform
ChatGPT
18
Perplexity
36
Gemini
26

About

Clueso is a San Francisco-based AI product documentation platform — backed by Y Combinator (W23) with $1.9 million raised including a $1.4 million seed round in 2024 from F7 Ventures, Shift Left Ventures, and YC — providing software companies, SaaS businesses, and product teams with an AI system that transforms screen recordings into studio-quality video tutorials, step-by-step written help articles, and multilingual documentation in 16+ languages, delivering 80% reduction in documentation creation time and 10x improvement in documentation quality versus manual production. Founded in 2023 by Akash Anand, Prajwal Prakash, and Neel Balar (IIT Madras graduates), Clueso automates the customer education and employee onboarding documentation workflows that product and customer success teams spend significant time creating and maintaining.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

25
Overall Score
41
#886
Category Rank
#220
61
AI Consensus
62
up
Trend
up
18
ChatGPT
49
36
Perplexity
36
26
Gemini
40
28
Claude
41
28
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.